Please register and log-in to create and edit pages

User Tools

    Please register and log-in to create and edit pages

Site Tools


Main Menu

Main menu
Click categories to expand


A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing

This is an alphabetical index of all content pages.


Other categories

Utilities

Contacts
Register

Also see

Importance Ratings
News
Legal
Donate/Sponsor


Wikenigma supports:


Feeds etc
rss / xml feed
sitemap file
A-Z listing (archived)


Auto-Translate Site

Wikenigma - an Encyclopedia of Unknowns Wikenigma - an Encyclopedia of the Unknown

Rufinamide

Rufinamide (sold under the brand names Banzel, Inovelon and others) is an anti-convulsant medication used to treat seizure disorders - such as severe Epilepsyplugin-autotooltip__plain plugin-autotooltip_bigEpilepsy

"“Epilepsy is a chronic noncommunicable disease of the brain that affects around 50 million people worldwide. It is characterized by recurrent seizures, which are brief episodes of involuntary movement that may involve a part of the body (partial) or the enti…
. It was approved by the US FDA in 2008,

Its 'mechanism of action' is currently unknown.

Structurally unrelated to other antiepileptic drugs, rufinamide is thought to act primarily by prolonging the inactivation phase of voltage-gated sodium channels.
Epileptic Disorders . 2018 Feb 1;20(1):13-29


    Share this page :

Dear reader : Do you have any suggestions for the site's content?

Ideas for new topics, and suggested additions / corrections for old ones, are always welcome.

If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !


Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.

( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)

Automatic Translation

You are currently viewing an auto-translated version of Wikenigma

Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.

Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.

Show another (random) page

DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK SEPTEMBER 2021